Nicolas Roussot

Tumor Immunogenic Cell Death as a Mediator of Intratumor CD8 T-Cell Recruitment

F. Ghiringhelli, C. Rébé, Nicolas Roussot, 2022, Cells.

Clinical Utility of Genomic Tests Evaluating Homologous Recombination Repair Deficiency (HRD) for Treatment Decisions in Early and Metastatic Breast Cancer

R. Boidot, F. Ghiringhelli, S. Ladoire, 2023, Cancers.

A phase I study of the combination of atezolizumab, tiragolumab, and stereotactic body radiation therapy in patients with metastatic multiorgan cancer

A. Bertaut, Jean-David Fumet, E. Limagne, 2023, BMC Cancer.

FOLFIRI-bevacizumab as a second-line treatment for advanced biliary tract cancer after gemcitabine-based chemotherapy

L. Bengrine, J. Vincent, Rémi Palmier, 2023, Frontiers in Oncology.

FGF/FGFR genomic amplification as a predictive biomarker for immune checkpoint blockade resistance: a short report

C. Truntzer, Lorraine Dalens, J. Lecuelle, 2023, Journal for ImmunoTherapy of Cancer.

Effect of radiochemotherapy on peripheral immune response in glioblastoma

J. Vincent, E. Limagne, C. Truntzer, 2024, Cancer immunology, immunotherapy : CII.